CLLassify SIGNED
Innovative risk assessment for individualizing treatment in chronic lymphocytic leukemia
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0CLLassify project word cloud
Explore the words cloud of the CLLassify project. It provides you a very rough idea of what is the project "CLLassify" about.
Project "CLLassify" data sheet
The following table provides information about the project.
| Coordinator |
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS
Organization address contact info |
| Coordinator Country | Greece [EL] |
| Project website | http://cllassify.gr/ |
| Total cost | 164˙653 € |
| EC max contribution | 164˙653 € (100%) |
| Programme |
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility) |
| Code Call | H2020-MSCA-IF-2015 |
| Funding Scheme | MSCA-IF-EF-ST |
| Starting year | 2016 |
| Duration (year-month-day) | from 2016-04-01 to 2018-03-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS | EL (THERMI THESSALONIKI) | coordinator | 164˙653.00 |
Map
Project objective
Chronic lymphocytic leukemia faces high-challenging and timely problems related to the classification and efficient prognosis of patients at the time of diagnosis and the attempt to personalize the treatment. CLLassify addresses these issues in a pioneering fashion within a multidisciplinary collaboration, proposing an improved classification of the patients, based on innovative statistical techniques as well as the novel aspect of personalized prediction of the need for treatment at a specific time point for the individual patient. The statistical background of the applicant, together with the expertise of his supervisor in CLL, guarantee the successful implementation of this project. This will result both in significant health advances and societal benefits for the European society at large raising the project at the level of a European priority, and to significant improvement of the applicant’s career prospects within Europe.
Publications
| year | authors and title | journal | last update |
|---|---|---|---|
| 2016 |
P. Baliakas, A. Puiggros, A. Xochelli, L.-A. Sutton, F. Nguyen-Khac, A. Gardiner, K. Plevova, E. Minga, A. Hadzidimitriou, R. Walewska, H. McCarthy, M. Ortega, R. Collado, T. Gonzalez, I. Granada, E. Luno, J. Kota kova, T. Moysiadis, Z. Davis, N. Stavroyianni, A. Anagnostopoulos, J. C. Strefford, S. Pospisilova, F. Davi, A. Athanasiadou, R. Rosenquist, D. Oscier, B. Espinet, K. Stamatopoulos Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference published pages: e299-e302, ISSN: 0390-6078, DOI: 10.3324/haematol.2015.140202 |
Haematologica 101/7 | 2019-06-13 |
| 2016 |
Nikos Papakonstantinou, Stavroula Ntoufa, Elisavet Chartomatsidou, Konstantia Kotta, Andreas Agathangelidis, Lefki Giassafaki, Tzeni Karamanli, Panagiota Bele, Theodoros Moysiadis, Panagiotis Baliakas, Lesley Ann Sutton, Niki Stavroyianni, Achilles Anagnostopoulos, Antonios M. Makris, Paolo Ghia, Richard Rosenquist, Kostas Stamatopoulos The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia published pages: 35946–35959, ISSN: 1949-2553, DOI: 10.18632/oncotarget.9371 |
Oncotarget 7/24 | 2019-06-13 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLLASSIFY" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "CLLASSIFY" are provided by the European Opendata Portal: CORDIS opendata.